Miromatrix Medical Inc.
Miromatrix Medical Inc. (MIRO) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
miro · stock forecast · 2 analysts (3M) · FMP · updated Nov 4, 2024
Analyst Rating & Consensus
Based on 2 Wall Street analysts in the past 3 months
Buy
2 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$9.00
Consensus
$9.00
+165.5% upside
Low
$9.00
Median: $9 · Last Close: $3.39
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MIRO · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-05-12 | Piper Sandler | Maintains | Overweight→Overweight |
| 2023-05-11 | Piper Sandler | Maintains | Overweight→Overweight |
| 2023-04-03 | Piper Sandler | Maintains | Overweight→Overweight |
| 2023-04-02 | Piper Sandler | Maintains | Overweight→Overweight |
| 2022-11-15 | Piper Sandler | Maintains | Overweight→Overweight |
| 2022-11-14 | Piper Sandler | Maintains | Overweight→Overweight |
| 2022-08-31 | Piper Sandler | Maintains | Overweight→Overweight |
| 2021-07-19 | Craig-Hallum | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Miromatrix Medical Inc. (MIRO) stock. Of the recent 8 rating actions, 0 were upgrades and 0 were downgrades. 2 analysts currently cover MIRO.
Analyst Recommendation Trends
MIRO analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 64.2% YoY
Revenue Next Year
$1M
↑ 17773.1% YoY
EPS This Year
$-0.04
EPS Next Year
$-1.25
↑ 3020.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast MIRO EPS of $-0.04 for the current fiscal year, based on estimates from 0 analysts. The MIRO revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The MIRO stock forecast is supported by two independent data sources: analyst consensus ratings from 2 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MIRO price target is $9.00 (+165.5% upside), with an analyst consensus of Buy.
Miromatrix Medical Inc. trades on NASDAQ under the ticker MIRO. The MIRO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
MIRO forecast · 8 questionsAccording to 2 Wall Street analysts, the average 12-month MIRO price target is $9.00, with a high forecast of $9.00 and a low of $9.00. The median price target is shown in the chart above when available. This implies +165.5% potential upside from the current price of $3.39.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.